Brazil's FBM Industria licenses Ampio's quick-dissolve premature-ejaculation pill

Ampio Pharmaceuticals ($AMPE) has licensed its fast-dissolving, premature-ejaculation pill, Zertane, to a Brazilian firm to market the drug there. Ampio announced its partnership with FBM Industria Farmaceutica this week, in keeping with its strategy to join forces with companies around the world to proliferate sales of its yet-to-be-approved drug. Ampio struck a similar deal with Korean firm Daewong Pharmaceuticals in September. Zertane, which completed Phase III trials in Europe last year, uses Ampio's proprietary fast-dissolve drug-delivery method, allowing users to take the pill without water and without a bitter aftertaste. Under the licensing agreements, the foreign firms can market and distribute the drug in their countries but must get regulatory approval on their own. Release

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

A self-injection pen prefilled with Brussels-based UCB’s Cimzia (certolizumab pegol) has been made available this week in the U.K. after a positive opinion…

Everstone, a private equity firm specializing in India and Southeast Asia, has finally decided to shell out Rs 220 crore ($33 million) to obtain a 70% stake--a…